3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
115
Gliosarcoma
53
Brain Neoplasms
53
Glioma
47
Central Nervous System Neoplasms
30
Astrocytoma
29
Melanoma
26
Oligodendroglioma
14
Neuroblastoma
10
Neoplasm Metastasis
9
Recurrence
7
Ependymoma
7
Sarcoma
6
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Skin Neoplasms
5
Sarcoma, Ewing
5
Lymphoma
5
Breast Neoplasms
5
Spinal Cord Neoplasms
4
Somatostatinoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Medulloblastoma
4
Colorectal Neoplasms
4
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Gastrinoma
3
Carcinoma, Islet Cell
3
Uveal Melanoma
2
Rhabdomyosarcoma
2
Interventions
pazopanib
4
Doxorubicin
4
Sirolimus
3
Ifosfamide
3
Sorafenib
2
Radiotherapy
2
Etoposide
2
thymoglobulin
1
temsirolimus
1
tazemetostat
1
sapanisertib
1
romidepsin
1
pexidartinib
1
lorvotuzumab mertansine
1
liposomal doxorubicin
1
indolepropanol phosphate
1
fludarabine phosphate
1
Watchful Waiting
1
Thiotepa
1
Tacrolimus
1
Sunitinib
1
Stem Cell Transplantation
1
STA 9090
1
Razoxane
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiation
1
Polymerase Chain Reaction
1
Observation
1
Neoadjuvant Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neurofibrosarcoma
×
Temozolomide
×
Clear all
No trials found.